Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK wins priority status for new HIV drug in U.S.
GSK wins priority status for new HIV drug in U.S.
GSK wins priority status for new HIV drug in U.S.
Submitted by
admin
on February 15, 2013 - 11:23am
Source:
Reuters
News Tags:
GSK
HIV
Shionogi
ViiV Healthcare
Dolutegravir
Headline:
GSK wins priority status for new HIV drug in U.S.
Do Not Allow Advertisers to Use My Personal information
